Latest On Jounce Therapeutics, Inc (JNCE):
About Jounce Therapeutics, Inc (JNCE):
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-4014, an anti-PD-1 antibody for combination therapy; JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts.
General
- Name Jounce Therapeutics, Inc
- Symbol JNCE
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 128
- Fiscal Year EndDecember
- IPO Date2017-01-27
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://jouncetx.com
Valuation
- Trailing PE 11.8
- Forward PE 28.49
- Price/Sales (Trailing 12 Mt.) 6.96
- Price/Book (Most Recent Quarter) 2.63
- Enterprise Value Revenue 5.88
- Enterprise Value EBITDA 6.8
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.44
- Next Year EPS Estimate -$2.10
- Next Quarter EPS Estimate -$0.44
- Profit Margin -70%
- Operating Margin -72%
- Return on Assets -13%
- Return on Equity -23%
- Revenue 62.34 million
- Earnings Per Share $0.63
- Revenue Per Share $1.76
- Gross Profit 25.35 million
- Quarterly Earnings Growth 722.2%
Highlights
- Market Capitalization 574.85 million
- EBITDA 22.6 million
- Analyst Target Price $16
- Book Value Per Share $5.06
Share Statistics
- Shares Outstanding 51.14 million
- Shares Float 34.3 million
- % Held by Insiders 2314%
- % Held by Institutions 63.38%
- Shares Short 618517
- Shares Short Prior Month 1.07 million
- Short Ratio 1.87
- Short % of Float 2%
- Short % of Shares Outstanding 1%
Technicals
- Beta 1.2
- 52 Week High $14.84
- 52 Week Low $3.57
- 50 Day Moving Average 11.95
- 200 Day Moving Average 9.05
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Jounce Therapeutics, Inc (JNCE) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Jounce Therapeutics, Inc (JNCE) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $N/A | $0.86 | $0.04 | 2133.77% |
2020-09-30 | 2020-11-06 | $N/A | -$0.73 | -$0.78 | 5.88% |
2020-06-30 | 2020-08-07 | $N/A | -$0.82 | -$0.72 | -13.37% |
2020-03-31 | 2020-05-06 | $N/A | -$0.78 | -$0.58 | -34.76% |
2019-12-31 | 2020-02-27 | $N/A | -$0.68 | -$0.57 | -19.3% |
2019-09-30 | 2019-11-07 | $119.45 million | $2.90 | $2.24 | 29.73% |
2019-06-30 | 2019-08-07 | $17.45 million | -$0.21 | -$0.34 | 37.31% |
2019-03-31 | 2019-05-08 | $10.98 million | -$0.38 | -$0.26 | -44.32% |
2018-12-31 | 2019-03-06 | $20.1 million | -$0.06 | -$0.36 | 83.43% |
2018-09-30 | 2018-11-13 | $14.53 million | -$0.23 | -$0.35 | 34.23% |
2018-06-30 | 2018-08-09 | $19.38 million | -$0.14 | -$0.37 | 61.65% |
2018-03-31 | 2018-05-09 | $11.2 million | -$0.40 | -$0.31 | -27.31% |
2017-12-31 | 2018-03-08 | $12.99 million | -$0.29 | -$0.36 | 20.07% |
2017-09-30 | 2017-11-13 | $18.08 million | -$0.13 | -$0.25 | 47.85% |
2017-06-30 | 2017-08-09 | $20.29 million | -$0.11 | -$0.15 | 26.22% |
2017-03-31 | 2017-05-09 | $20.29 million | -$0.02 | -$0.09 | 78% |
2016-12-31 | 2017-03-10 | $20.29 million | $0.05 | -$0.01 | 631.91% |
Jounce Therapeutics, Inc (JNCE) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Jounce Therapeutics, Inc (JNCE) Chart:
Jounce Therapeutics, Inc (JNCE) News:
Below you will find a list of latest news for Jounce Therapeutics, Inc (JNCE) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Jounce Therapeutics, Inc (JNCE) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest JNCE Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:58 PM EST | 131 | $3.025 |
Jun 13, 2022 7:58 PM EST | 69 | $3.025 |
Jun 13, 2022 7:58 PM EST | 100 | $3.025 |
Jun 13, 2022 7:59 PM EST | 31 | $3.025 |
Jun 13, 2022 7:59 PM EST | 51 | $3.025 |
Jounce Therapeutics, Inc (JNCE) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000091/0001640455-20-000091-index.htm |
2018-03-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1640455/000000000018008343/0000000000-18-008343-index.htm |
2018-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1640455/000031506618002542/0000315066-18-002542-index.htm |
2018-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1640455/000090221918000320/0000902219-18-000320-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1640455/000090221919000315/0000902219-19-000315-index.htm |
2020-10-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1640455/000110465920118184/0001104659-20-118184-index.htm |
2020-10-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000110465920118186/0001104659-20-118186-index.htm |
2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1640455/000114420418008872/0001144204-18-008872-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1640455/000114420419008379/0001144204-19-008379-index.htm |
2018-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1640455/000119312518042505/0001193125-18-042505-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000013/0001640455-18-000013-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000014/0001640455-18-000014-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000015/0001640455-18-000015-index.htm |
2018-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000022/0001640455-18-000022-index.htm |
2018-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm |
2018-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm |
2018-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000028/0001640455-18-000028-index.htm |
2018-03-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000030/0001640455-18-000030-index.htm |
2018-03-08 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000034/0001640455-18-000034-index.htm |
2018-03-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000035/0001640455-18-000035-index.htm |
2018-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000039/0001640455-18-000039-index.htm |
2018-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000040/0001640455-18-000040-index.htm |
2018-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000041/0001640455-18-000041-index.htm |
2018-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000043/0001640455-18-000043-index.htm |
2018-04-09 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000046/0001640455-18-000046-index.htm |
2018-04-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000047/0001640455-18-000047-index.htm |
2018-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000053/0001640455-18-000053-index.htm |
2018-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000054/0001640455-18-000054-index.htm |
2018-04-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000055/0001640455-18-000055-index.htm |
2018-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000059/0001640455-18-000059-index.htm |
2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000062/0001640455-18-000062-index.htm |
2018-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000064/0001640455-18-000064-index.htm |
2018-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000068/0001640455-18-000068-index.htm |
2018-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000070/0001640455-18-000070-index.htm |
2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000072/0001640455-18-000072-index.htm |
2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000080/0001640455-18-000080-index.htm |
2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000081/0001640455-18-000081-index.htm |
2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000082/0001640455-18-000082-index.htm |
2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000083/0001640455-18-000083-index.htm |
2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000084/0001640455-18-000084-index.htm |
2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000085/0001640455-18-000085-index.htm |
2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000086/0001640455-18-000086-index.htm |
2018-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000089/0001640455-18-000089-index.htm |
2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000093/0001640455-18-000093-index.htm |
2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000095/0001640455-18-000095-index.htm |
2018-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000099/0001640455-18-000099-index.htm |
2018-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000100/0001640455-18-000100-index.htm |
2018-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000101/0001640455-18-000101-index.htm |
2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000103/0001640455-18-000103-index.htm |
2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000105/0001640455-18-000105-index.htm |
2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000109/0001640455-18-000109-index.htm |
2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000111/0001640455-18-000111-index.htm |
2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000113/0001640455-18-000113-index.htm |
2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000004/0001640455-19-000004-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000009/0001640455-19-000009-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000010/0001640455-19-000010-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000011/0001640455-19-000011-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000012/0001640455-19-000012-index.htm |
2019-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000017/0001640455-19-000017-index.htm |
2019-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000021/0001640455-19-000021-index.htm |
2019-03-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000022/0001640455-19-000022-index.htm |
2019-04-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000025/0001640455-19-000025-index.htm |
2019-04-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000026/0001640455-19-000026-index.htm |
2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000030/0001640455-19-000030-index.htm |
2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000036/0001640455-19-000036-index.htm |
2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000053/0001640455-19-000053-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000054/0001640455-19-000054-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000055/0001640455-19-000055-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000056/0001640455-19-000056-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000057/0001640455-19-000057-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000058/0001640455-19-000058-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000059/0001640455-19-000059-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000060/0001640455-19-000060-index.htm |
2019-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000062/0001640455-19-000062-index.htm |
2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000065/0001640455-19-000065-index.htm |
2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000071/0001640455-19-000071-index.htm |
2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm |
2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm |
2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm |
2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000081/0001640455-19-000081-index.htm |
2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000084/0001640455-19-000084-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000087/0001640455-19-000087-index.htm |
2019-12-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000091/0001640455-19-000091-index.htm |
2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000093/0001640455-19-000093-index.htm |
2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000095/0001640455-19-000095-index.htm |
2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000002/0001640455-20-000002-index.htm |
2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000003/0001640455-20-000003-index.htm |
2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000004/0001640455-20-000004-index.htm |
2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000005/0001640455-20-000005-index.htm |
2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000006/0001640455-20-000006-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000008/0001640455-20-000008-index.htm |
2020-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000011/0001640455-20-000011-index.htm |
2020-01-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000012/0001640455-20-000012-index.htm |
2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000014/0001640455-20-000014-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000019/0001640455-20-000019-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000020/0001640455-20-000020-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000021/0001640455-20-000021-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000022/0001640455-20-000022-index.htm |
2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000029/0001640455-20-000029-index.htm |
2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000034/0001640455-20-000034-index.htm |
2020-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000035/0001640455-20-000035-index.htm |
2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000037/0001640455-20-000037-index.htm |
2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000042/0001640455-20-000042-index.htm |
2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000043/0001640455-20-000043-index.htm |
2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000048/0001640455-20-000048-index.htm |
2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000051/0001640455-20-000051-index.htm |
2020-06-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000054/0001640455-20-000054-index.htm |
2020-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000056/0001640455-20-000056-index.htm |
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000059/0001640455-20-000059-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000068/0001640455-20-000068-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000069/0001640455-20-000069-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000070/0001640455-20-000070-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000071/0001640455-20-000071-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000072/0001640455-20-000072-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000073/0001640455-20-000073-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000074/0001640455-20-000074-index.htm |
2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000075/0001640455-20-000075-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000084/0001640455-20-000084-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000085/0001640455-20-000085-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000086/0001640455-20-000086-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000087/0001640455-20-000087-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000088/0001640455-20-000088-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000089/0001640455-20-000089-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000090/0001640455-20-000090-index.htm |
2020-07-02 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000091/0001640455-20-000091-index.htm |
2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000100/0001640455-20-000100-index.htm |
2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000103/0001640455-20-000103-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm |
2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000112/0001640455-20-000112-index.htm |
2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000114/0001640455-20-000114-index.htm |
2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm |
2020-10-29 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000118/0001640455-20-000118-index.htm |
2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000120/0001640455-20-000120-index.htm |
2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000125/0001640455-20-000125-index.htm |
2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000127/0001640455-20-000127-index.htm |
2018-05-01 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1640455/999999999518001058/9999999995-18-001058-index.htm |
2020-02-12 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1640455/999999999720000654/9999999997-20-000654-index.htm |
2020-03-03 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1640455/999999999720001106/9999999997-20-001106-index.htm |
Jounce Therapeutics, Inc (JNCE) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jounce Therapeutics, Inc (JNCE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2314%Institutional Ownership: 6338%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-03-15 | Barbara Gayle Duncan | Director | Sell | 2,000.00 | 28.11 | 56,220.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000043/0001640455-18-000043-index.htm |
2020-09-15 | Barbara Gayle Duncan | Director | Sell | 5,000.00 | 10.50 | 52,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm |
2018-03-05 | Elizabeth Trehu | Chief Medical Officer | Sell | 1,366.00 | 22.11 | 30,202.26 | 0.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm |
2018-03-08 | Elizabeth Trehu | Chief Medical Officer | Sell | 4,545.00 | 25.06 | 113,897.70 | 0.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000041/0001640455-18-000041-index.htm |
2018-03-08 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 5,267.00 | 25.01 | 131,727.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000039/0001640455-18-000039-index.htm |
2018-03-05 | RICHARD /CA/ MURRAY | CEO and President | Sell | 4,234.00 | 22.06 | 93,402.04 | 0.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm |
2018-03-08 | RICHARD /CA/ MURRAY | CEO and President | Sell | 16,334.00 | 25.10 | 409,983.40 | 0.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000040/0001640455-18-000040-index.htm |
2020-09-15 | Barbara Gayle Duncan | Director | Buy | 10,000.00 | 4.21 | 42,100.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm |
2020-01-06 | John Duncan Higgons | Director | Sell | 1,500.00 | 8.11 | 12,165.00 | 12,013.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000002/0001640455-20-000002-index.htm |
2019-12-23 | RICHARD /CA/ MURRAY | CEO and President | Buy | 40,000.00 | 0.48 | 19,200.00 | 134,510.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000095/0001640455-19-000095-index.htm |
2018-03-05 | Elizabeth Trehu | Chief Medical Officer | Sell | 3,179.00 | 21.24 | 67,521.96 | 1,366.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm |
2018-08-13 | Kimberlee C Drapkin | CFO and Treasurer | Buy | 14,400.00 | 14,400.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000099/0001640455-18-000099-index.htm | ||
2018-03-05 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 1,267.00 | 22.07 | 27,962.69 | 1,508.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000022/0001640455-18-000022-index.htm |
2020-02-03 | RICHARD /CA/ MURRAY | CEO and President | Buy | 75,010.00 | 162,370.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000020/0001640455-20-000020-index.htm | ||
2018-08-13 | Hugh M Cole | Chief Business Officer | Buy | 14,400.00 | 16,300.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000100/0001640455-18-000100-index.htm | ||
2018-03-05 | RICHARD /CA/ MURRAY | CEO and President | Buy | 16,334.00 | 0.48 | 7,840.32 | 16,334.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm |
2018-03-08 | RICHARD /CA/ MURRAY | CEO and President | Buy | 16,334.00 | 0.48 | 7,840.32 | 16,334.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000040/0001640455-18-000040-index.htm |
2018-06-15 | Hugh M Cole | Chief Business Officer | Buy | 1,900.00 | 7.84 | 14,896.00 | 1,900.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000072/0001640455-18-000072-index.htm |
2018-03-15 | Barbara Gayle Duncan | Director | Buy | 2,000.00 | 4.21 | 8,420.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000043/0001640455-18-000043-index.htm |
2018-06-08 | Elizabeth Trehu | Chief Medical Officer | Buy | 24,875.00 | 4.02 | 99,997.50 | 24,875.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000070/0001640455-18-000070-index.htm |
2018-08-27 | Kimberlee C Drapkin | CFO and Treasurer | Buy | 12,700.00 | 2.36 | 29,972.00 | 27,100.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000103/0001640455-18-000103-index.htm |
2018-03-05 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 4,000.00 | 21.21 | 84,840.00 | 2,775.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000022/0001640455-18-000022-index.htm |
2018-09-06 | RICHARD /CA/ MURRAY | CEO and President | Buy | 32,000.00 | 0.48 | 15,360.00 | 32,000.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000105/0001640455-18-000105-index.htm |
2020-01-07 | Hugh M Cole | Chief Business Officer | Sell | 2,624.00 | 7.78 | 20,414.72 | 33,590.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000003/0001640455-20-000003-index.htm |
2019-08-16 | Hugh M Cole | Chief Business Officer | Sell | 1,018.00 | 3.92 | 3,990.56 | 36,214.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm |
2019-08-15 | Hugh M Cole | Chief Business Officer | Sell | 648.00 | 4.00 | 2,592.00 | 37,232.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm |
2019-08-14 | Hugh M Cole | Chief Business Officer | Sell | 670.00 | 4.10 | 2,747.00 | 37,880.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm |
2019-02-01 | Hugh M Cole | Chief Business Officer | Buy | 22,250.00 | 38,550.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000011/0001640455-19-000011-index.htm | ||
2018-08-13 | Elizabeth Trehu | Chief Medical Officer | Buy | 14,400.00 | 39,275.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000101/0001640455-18-000101-index.htm | ||
2018-03-05 | RICHARD /CA/ MURRAY | CEO and President | Sell | 12,100.00 | 21.21 | 256,641.00 | 4,234.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm |
2020-01-07 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 2,624.00 | 7.78 | 20,414.72 | 44,390.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000006/0001640455-20-000006-index.htm |
2018-03-05 | Elizabeth Trehu | Chief Medical Officer | Buy | 4,545.00 | 4.02 | 18,270.90 | 4,545.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm |
2018-03-08 | Elizabeth Trehu | Chief Medical Officer | Buy | 4,545.00 | 4.02 | 18,270.90 | 4,545.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000041/0001640455-18-000041-index.htm |
2019-08-16 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 1,018.00 | 3.92 | 3,990.56 | 47,014.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm |
2019-08-15 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 648.00 | 4.00 | 2,592.00 | 48,032.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm |
2019-08-14 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 670.00 | 4.10 | 2,747.00 | 48,680.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm |
2019-02-01 | Kimberlee C Drapkin | CFO and Treasurer | Buy | 22,250.00 | 49,350.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000010/0001640455-19-000010-index.htm | ||
2020-09-15 | Barbara Gayle Duncan | Director | Sell | 5,000.00 | 9.50 | 47,500.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm |
2018-03-08 | Kimberlee C Drapkin | CFO and Treasurer | Buy | 3,759.00 | 0.48 | 1,804.32 | 5,267.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045518000039/0001640455-18-000039-index.htm |
2020-01-07 | Elizabeth Trehu | Chief Medical Officer | Sell | 2,624.00 | 7.78 | 20,414.72 | 56,565.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000005/0001640455-20-000005-index.htm |
2019-08-16 | Elizabeth Trehu | Chief Medical Officer | Sell | 1,018.00 | 3.92 | 3,990.56 | 59,189.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm |
2019-08-15 | Elizabeth Trehu | Chief Medical Officer | Sell | 648.00 | 4.00 | 2,592.00 | 60,207.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm |
2019-08-14 | Elizabeth Trehu | Chief Medical Officer | Sell | 670.00 | 4.10 | 2,747.00 | 60,855.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm |
2020-08-18 | Hugh M Cole | Chief Business Officer | Sell | 744.00 | 4.71 | 3,504.24 | 61,408.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm |
2019-02-01 | Elizabeth Trehu | Chief Medical Officer | Buy | 22,250.00 | 61,525.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000012/0001640455-19-000012-index.htm | ||
2020-09-01 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 7,200.00 | 8.06 | 58,032.00 | 61,708.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000114/0001640455-20-000114-index.htm |
2020-08-17 | Hugh M Cole | Chief Business Officer | Sell | 454.00 | 4.86 | 2,206.44 | 62,152.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm |
2020-08-14 | Hugh M Cole | Chief Business Officer | Sell | 984.00 | 4.64 | 4,565.76 | 62,606.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm |
2020-02-03 | Hugh M Cole | Chief Business Officer | Buy | 30,000.00 | 63,590.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000021/0001640455-20-000021-index.htm | ||
2020-08-18 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 744.00 | 4.71 | 3,504.24 | 68,908.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm |
2020-08-17 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 454.00 | 4.86 | 2,206.44 | 69,652.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm |
2020-08-14 | Kimberlee C Drapkin | CFO and Treasurer | Sell | 984.00 | 4.64 | 4,565.76 | 70,106.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm |
2020-02-03 | Kimberlee C Drapkin | CFO and Treasurer | Buy | 26,700.00 | 71,090.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000019/0001640455-20-000019-index.htm | ||
2020-08-14 | Elizabeth Trehu | Chief Medical Officer | Sell | 744.00 | 4.71 | 3,504.24 | 76,633.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm |
2020-08-17 | Elizabeth Trehu | Chief Medical Officer | Sell | 454.00 | 4.86 | 2,206.44 | 77,377.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm |
2020-08-14 | Elizabeth Trehu | Chief Medical Officer | Sell | 984.00 | 4.64 | 4,565.76 | 77,831.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm |
2020-02-03 | Elizabeth Trehu | Chief Medical Officer | Buy | 22,250.00 | 78,815.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000022/0001640455-20-000022-index.htm | ||
2020-01-07 | RICHARD /CA/ MURRAY | CEO and President | Sell | 7,150.00 | 7.78 | 55,627.00 | 87,360.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045520000004/0001640455-20-000004-index.htm |
2019-02-01 | RICHARD /CA/ MURRAY | CEO and President | Buy | 62,510.00 | 94,510.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000009/0001640455-19-000009-index.htm | ||
2019-12-23 | RICHARD /CA/ MURRAY | CEO and President | Sell | 40,000.00 | 8.37 | 334,800.00 | 94,510.00 | https://www.sec.gov/Archives/edgar/data/1640455/000164045519000095/0001640455-19-000095-index.htm |